Physician profile
Nader S Eldika
NPI 1033231006
$9,163.27
in general payments reported to CMS, 2019-2025
37 companies · $2,072 in 2025
The $2,072 reported for 2025 was more than what 76% of Pulmonary Disease providers received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,085 · 2020: $45.68 · 2021: $1,206 · 2022: $1,361 · 2023: $1,635 · 2024: $1,759 · 2025: $2,072.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,235 · Education: $231.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,235.29 |
| Education | $230.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $2,033.83 | 2019-2025 | Trelegy Ellipta, Nucala, Arexvy |
| Astrazeneca Pharmaceuticals Lp | $1,807.69 | 2019-2025 | Airsupra, Breztri, Fasenra |
| Actelion Pharmaceuticals US, INC. | $964.04 | 2019-2025 | Uptravi, Opsumit, Opsynvi |
| Boehringer Ingelheim Pharmaceuticals, INC. | $824.39 | 2019-2025 | Ofev |
| Genzyme Corporation | $361.42 | 2021-2025 | |
| Genentech USA, INC. | $348.92 | 2019-2025 | Xolair |
| Regeneron Healthcare Solutions, INC. | $347.74 | 2019-2025 | Dupixent |
| United Therapeutics Corporation | $314.65 | 2019-2025 | |
| Axsome Therapeutics, INC. | $217.32 | 2023-2025 | Sunosi |
| Grifols USA, LLC | $173.66 | 2022-2025 | Prolastin-C Liquid |
| Takeda Pharmaceuticals U.S.A., INC. | $161.05 | 2021-2025 | Glassia |
| Novartis Pharmaceuticals Corporation | $155.31 | 2019-2024 | |
| Sunovion Pharmaceuticals INC. | $142.37 | 2019 | |
| Mylan Specialty L.P. | $142.32 | 2019-2024 | Yupelri |
| Allergan, INC. | $132.97 | 2019 |
Show all 37 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Jazz Pharmaceuticals INC. | $123.05 | 2021-2025 | |
| Amgen INC. | $104.69 | 2019-2025 | Tezspire |
| Janssen Biotech, INC. | $89.54 | 2021-2024 | Erleada |
| Advanced Respiratory, INC | $85.99 | 2021 | |
| Sanofi-Aventis U.S. LLC | $74.97 | 2019-2023 | |
| Viatris Specialty LLC | $72.41 | 2025 | Yupelri |
| Bayer Healthcare Pharmaceuticals INC. | $62.54 | 2022-2023 | |
| Baxter Healthcare | $55.43 | 2022-2023 | Hillrom - Life 2000 Ventilation System |
| Verona Pharma, INC. | $42.11 | 2025 | Ohtuvayre |
| Merck Sharp & Dohme LLC | $39.82 | 2021-2024 | Winrevair |
| Janssen Pharmaceuticals, INC | $35.24 | 2022 | |
| Teva Pharmaceuticals USA, INC. | $34.20 | 2021 | |
| Insmed, INC. | $33.01 | 2025 | Brinsupri, Arikayce |
| La Jolla Pharmaceutical Company | $29.98 | 2021 | |
| Sanofi Pasteur INC. | $23.47 | 2019 | |
| Resmed Corp | $22.50 | 2023 | |
| Mallinckrodt Hospital Products INC. | $20.40 | 2023 | Acthar |
| Electromed, INC. | $19.96 | 2025 | Smartvest |
| Inspire Medical Systems, INC. | $19.11 | 2023 | Inspire |
| Philips North America LLC | $18.13 | 2022 | |
| Pfizer INC. | $15.26 | 2025 | |
| Circassia INC. | $13.78 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nader Eldika listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.